Is CG Oncology Inc. (CGON) a Buy, Sell, or Hold?
NASDAQ : CGON
CG Oncology Inc. — Institutional Ownership
$73.52 USD
$4.2 (6.06%)
- Volume
- 1.06M
- Average Volume
- 1.03M
- Market Capitalization
- $6.48B
- P/E Ratio
- -31.42
- Dividend Yield
- 0.00%
- Price Target
- $81.50
- Year High
- $77.00
- Year Low
- $23.65
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $31.30
Institutional Ownership Summary
Institutional Ownership %
0.23%
Investors Holding
22
change: -224 | last: 246
Increased Positions
11
change: -137 | last: 148
Reduced Positions
4
change: -59 | last: 63
New Positions
1
change: -63 | last: 64
Sold Positions
216
change: 190 | last: 26
Total Calls
-
Total Puts
-
Put-Call Ratio
0.00
change: -43.9545 | last: 0.4395
Total Invested
13.38M
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-05-15 | RTW Investments, LP | 6.98M | 8.30% |
| 2026-05-15 | T. Rowe Price Investment Management, Inc. | 6.72M | 8.00% |
| 2026-03-26 | The Vanguard Group | - | 0.00% |
| 2025-11-12 | Wellington Management Group LLP | 5.51M | 7.20% |
| 2025-10-30 | The Vanguard Group | 6.58M | 8.62% |
| 2025-10-28 | Seven Fleet Capital Management LP | 1.52M | 1.90% |
| 2025-10-28 | Seven Fleet Master Fund LP | 1.52M | 1.90% |
| 2025-10-28 | Brian Liu | 1.54M | 2.00% |
| 2025-10-28 | Seven Fleet Capital Management GP LLC | 1.52M | 1.90% |
| 2025-09-18 | Seven Fleet Advisors LLC | 1.52M | 1.90% |
| 2025-09-18 | Juliet Tammenoms Bakker | 4.66M | 6.00% |
| 2025-09-18 | Patrick G. Enright | 4.66M | 6.00% |
| 2025-09-18 | Longitude Prime Fund, L.P. | 1.47M | 1.90% |
| 2025-09-18 | Longitude Prime Partners, LLC | 1.47M | 1.90% |
| 2025-09-18 | Longitude Venture Partners IV, L.P. | 3.19M | 4.10% |
| 2025-09-18 | Longitude Capital Partners IV, LLC | 3.19M | 4.10% |
| 2025-09-18 | Brian Liu | 1.52M | 2.00% |
| 2025-09-18 | Seven Fleet Partners LP | 1.52M | 1.90% |
| 2025-08-06 | FMR LLC | 3.86M | 5.10% |
| 2025-05-15 | TCG Crossover GP I, LLC | 3.67M | 4.80% |
| 2025-02-14 | Decheng Capital Global Life Sciences Fund IV, L.P. | 5.32M | 7.00% |
| 2025-01-28 | Unique Diamond Investments Limited | 586.98K | 0.80% |
| 2024-11-08 | (1) BlackRock, Inc. | 3.57M | 5.30% |
| 2024-10-22 | (1) BlackRock, Inc. | 3.57M | 5.30% |
| 2024-07-22 | ORI Capital Inc. | 1.01M | 1.50% |
| 2024-07-22 | ORI Healthcare Fund, L.P. | 1.01M | 1.50% |
| 2024-07-22 | ORI Capital Holding Inc. | 1.01M | 1.50% |
| 2024-07-22 | ORI Holding II Inc. | 3.93M | 5.90% |
| 2024-07-22 | Healthcare Seed Limited | 4.94M | 7.40% |
| 2024-07-22 | SONG, Hong Fang | 5.56M | 8.30% |
| 2024-07-22 | Unique Diamond Investments Limited | 1.01M | 1.50% |
| 2024-07-22 | Charming Jade Limited | 3.93M | 5.90% |
| 2024-07-22 | ORI Healthcare Fund II, L.P. | 3.93M | 5.90% |
| 2024-07-22 | ORI Capital II Inc. | 3.93M | 5.90% |
| 2024-03-14 | Kissei Pharmaceutical Co., Ltd. | 3.54M | 5.30% |
| 2024-02-09 | TCG Crossover GP I, LLC | 3.57M | 5.40% |
| 2024-02-09 | Chen Yu | 3.57M | 5.40% |
| 2024-02-09 | TCG Crossover Fund I, L.P. | 3.57M | 5.40% |
| 2024-02-08 | Decheng Capital Global Healthcare GP, LLC | 500K | 0.80% |
| 2024-02-08 | Xiangmin Cui | 5.06M | 7.60% |
| 2024-02-08 | Decheng Capital Management IV (Cayman), LLC | 4.56M | 6.90% |
| 2024-02-08 | Decheng Capital Global Life Sciences Fund IV, L.P. | 4.56M | 6.90% |
| 2024-02-08 | Decheng Capital Global Healthcare Fund (Master), LP | 500K | 0.80% |
| 2024-02-05 | S Foresite Capital Management V, LLC (“FCM V”) | 692.55K | 1.10% |
| 2024-02-05 | Foresite Capital Fund V, L.P. (“FCF V”) | 692.55K | 1.10% |
| 2024-02-05 | S James Tananbaum (“Tananbaum”) | 3.6M | 5.70% |
| 2024-02-05 | Longitude Venture Partners IV, L.P. | 3.19M | 4.80% |
| 2024-02-05 | Longitude Prime Fund, L.P. | 1.47M | 2.20% |
| 2024-02-05 | S Foresite Capital Management VI, LLC (“FCM VI”) | 2.05M | 3.20% |
| 2024-02-05 | Longitude Prime Partners, LLC | 1.47M | 2.20% |
| 2024-02-05 | Longitude Capital Partners IV, LLC | 3.19M | 4.80% |
| 2024-02-05 | Juliet Tammenoms Bakker | 4.66M | 7.00% |
| 2024-02-05 | Patrick G. Enright | 4.66M | 7.00% |
| 2024-02-05 | S Foresite Capital Fund VI, L.P. (“FCF VI”) | 2.05M | 3.20% |
| 2024-02-05 | Foresite Capital Opportunity Management V, LLC (“FCM Opp V”) | 857.55K | 1.40% |
| 2024-02-05 | Opp V”) | 857.55K | 1.40% |
CGON Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $41.52 | 77.3M | $3.21B | $32.49M | $7.02M | $3.18B |
| 2024-12-31 | $28.68 | 62.5M | $1.79B | $257.07M | $238K | $1.54B |
| 2023-12-31 | $37.17 | 66.64M | $2.48B | $8.27M | $1.03M | $2.47B |
| 2022-12-31 | $37.17 | 66.64M | $2.48B | $88.14M | $15.94M | $2.4B |
| 2021-12-31 | $37.17 | 66.64M | $2.48B | $53.61M | $15.13M | $2.44B |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $67.68 | 84.52M | $5.72B | $33.7M | $7.58M | $5.69B |
| 2025-12-31 | $41.52 | 77.3M | $3.21B | $32.49M | $7.02M | $3.18B |
| 2025-09-30 | $40.28 | 76.73M | $3.09B | $45.14M | $7.24M | $3.05B |
| 2025-06-30 | $26.00 | 76.23M | $1.98B | $14.62M | $994K | $1.97B |
| 2025-03-31 | $24.49 | 76.19M | $1.87B | $41.47M | $1.04M | $1.83B |
| 2024-12-31 | $28.68 | 64.82M | $1.86B | $257.07M | $238K | $1.6B |
| 2024-09-30 | $37.73 | 67.14M | $2.53B | $43.41M | $296K | $2.49B |
| 2024-06-30 | $31.72 | 66.65M | $2.11B | $25.16M | $355K | $2.09B |
| 2024-03-31 | $42.76 | 66.64M | $2.85B | $77.47M | $404K | $2.77B |
| 2023-12-31 | $37.17 | 66.64M | $2.48B | $8.27M | $1.03M | $2.47B |
| 2023-09-30 | $37.17 | 66.64M | $2.48B | $10.27M | $517K | $2.47B |
| 2023-06-30 | $37.17 | 66.64M | $2.48B | -$ | -$ | $2.48B |